Connor, Clark & Lunn Investment Management (CC&L)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-286,480
| Closed | -$295K | – | 1447 |
|
|
2024
Q4 | $295K | Buy |
286,480
+5,887
| +2% | +$6.06K | ﹤0.01% | 1261 |
|
|
2024
Q3 | $331K | Buy |
280,593
+26,373
| +10% | +$31.1K | ﹤0.01% | 1207 |
|
|
2024
Q2 | $310K | Sell |
254,220
-50,114
| -16% | -$61.1K | ﹤0.01% | 1177 |
|
|
2024
Q1 | $663K | Buy |
304,334
+107,814
| +55% | +$235K | ﹤0.01% | 1025 |
|
|
2023
Q4 | $305K | Buy |
196,520
+50,586
| +35% | +$78.4K | ﹤0.01% | 1170 |
|
|
2023
Q3 | $188K | Sell |
145,934
-10,106
| -6% | -$13K | ﹤0.01% | 1245 |
|
|
2023
Q2 | $268K | Buy |
156,040
+21,731
| +16% | +$37.4K | ﹤0.01% | 1131 |
|
|
2023
Q1 | $203K | Sell |
134,309
-16,711
| -11% | -$25.2K | ﹤0.01% | 1095 |
|
|
2022
Q4 | $242K | Sell |
151,020
-59,679
| -28% | -$95.5K | ﹤0.01% | 1019 |
|
|
2022
Q3 | $306K | Buy |
210,699
+3,628
| +2% | +$5.27K | ﹤0.01% | 917 |
|
|
2022
Q2 | $379K | Buy |
207,071
+6,872
| +3% | +$12.6K | ﹤0.01% | 832 |
|
|
2022
Q1 | $535K | Sell |
200,199
-1,559
| -0.8% | -$4.17K | ﹤0.01% | 775 |
|
|
2021
Q4 | $874K | Buy |
201,758
+146,813
| +267% | +$636K | ﹤0.01% | 702 |
|
|
2021
Q3 | $280K | Buy |
+54,945
| New | +$280K | ﹤0.01% | 888 |
|
|
2021
Q2 | – | Sell |
-92,243
| Closed | -$713K | – | 996 |
|
|
2021
Q1 | $713K | Buy |
92,243
+33,764
| +58% | +$261K | ﹤0.01% | 744 |
|
|
2020
Q4 | $383K | Buy |
58,479
+35,092
| +150% | +$230K | ﹤0.01% | 758 |
|
|
2020
Q3 | $156K | Sell |
23,387
-24,167
| -51% | -$161K | ﹤0.01% | 858 |
|
|
2020
Q2 | $396K | Sell |
47,554
-51,894
| -52% | -$432K | ﹤0.01% | 793 |
|
|
2020
Q1 | $763K | Buy |
99,448
+68,673
| +223% | +$527K | 0.01% | 616 |
|
|
2019
Q4 | $256K | Buy |
+30,775
| New | +$256K | ﹤0.01% | 791 |
|
|
2017
Q3 | – | Sell |
-14,450
| Closed | -$224K | – | 830 |
|
|
2017
Q2 | $224K | Buy |
+14,450
| New | +$224K | ﹤0.01% | 720 |
|